Barbacid M - Search Results

1

Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

Leftheris K, Kline T, Vite GD, Cho YH, Bhide RS, Patel DV, Patel MM, Schmidt RJ, Weller HN, Andahazy ML, Carboni JM, Gullo-Brown JL, Lee FY, Ricca C, Rose WC, Yan N, Barbacid M, Hunt JT, Meyers CA, Seizinger BR, Zahler R, Manne V. Leftheris K, et al. Among authors: barbacid m. J Med Chem. 1996 Jan 5;39(1):224-36. doi: 10.1021/jm950642a. J Med Chem. 1996. PMID: 8568812

2

10'-Desmethoxystreptonigrin, a novel analog of streptonigrin.

Liu WC, Barbacid M, Bulgar M, Clark JM, Crosswell AR, Dean L, Doyle TW, Fernandes PB, Huang S, Manne V, et al. Liu WC, et al. Among authors: barbacid m. J Antibiot (Tokyo). 1992 Apr;45(4):454-7. doi: 10.7164/antibiotics.45.454. J Antibiot (Tokyo). 1992. PMID: 1592677 Free article.

3

Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

Carboni JM, Yan N, Cox AD, Bustelo X, Graham SM, Lynch MJ, Weinmann R, Seizinger BR, Der CJ, Barbacid M, et al. Carboni JM, et al. Among authors: barbacid m. Oncogene. 1995 May 18;10(10):1905-13. Oncogene. 1995. PMID: 7761092

4

Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.

Patel DV, Gordon EM, Schmidt RJ, Weller HN, Young MG, Zahler R, Barbacid M, Carboni JM, Gullo-Brown JL, Hunihan L, et al. Patel DV, et al. Among authors: barbacid m. J Med Chem. 1995 Feb 3;38(3):435-42. doi: 10.1021/jm00003a006. J Med Chem. 1995. PMID: 7853336

5

Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy.

Wittekind M, Mapelli C, Farmer BT 2nd, Suen KL, Goldfarb V, Tsao J, Lavoie T, Barbacid M, Meyers CA, Mueller L. Wittekind M, et al. Among authors: barbacid m. Biochemistry. 1994 Nov 22;33(46):13531-9. doi: 10.1021/bi00250a004. Biochemistry. 1994. PMID: 7947763

6

Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.

Bustelo XR, Suen KL, Leftheris K, Meyers CA, Barbacid M. Bustelo XR, et al. Among authors: barbacid m. Oncogene. 1994 Aug;9(8):2405-13. Oncogene. 1994. PMID: 8036025

7

K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.

Tapley P, Lamballe F, Barbacid M. Tapley P, et al. Among authors: barbacid m. Oncogene. 1992 Feb;7(2):371-81. Oncogene. 1992. PMID: 1312698

8

The trkB tyrosine protein kinase is a receptor for neurotrophin-4.

Klein R, Lamballe F, Bryant S, Barbacid M. Klein R, et al. Among authors: barbacid m. Neuron. 1992 May;8(5):947-56. doi: 10.1016/0896-6273(92)90209-v. Neuron. 1992. PMID: 1375038

9

ras oncogenes: their role in neoplasia.

Barbacid M. Barbacid M. Eur J Clin Invest. 1990 Jun;20(3):225-35. doi: 10.1111/j.1365-2362.1990.tb01848.x. Eur J Clin Invest. 1990. PMID: 2114981 Review. No abstract available.

10

Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells.

Suen KL, Bustelo XR, Barbacid M. Suen KL, et al. Among authors: barbacid m. Oncogene. 1995 Sep 7;11(5):825-31. Oncogene. 1995. PMID: 7675443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters